Recruiting Diabetic Retinopathy Studies in Scottsdale
About Diabetic Retinopathy Clinical Trials in Scottsdale
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 3 diabetic retinopathy clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 1,139 participants. Research is being sponsored by AbbVie, 4D Molecular Therapeutics, Boehringer Ingelheim. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Scottsdale — FAQ
Are there diabetic retinopathy clinical trials in Scottsdale?
Yes, there are 3 diabetic retinopathy clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Scottsdale?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.
Are clinical trials in Scottsdale free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 3 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated October 15, 2026 from ClinicalTrials.gov